Randomized Controlled Phase II Trial of Pre-operative Celecoxib Treatment in Breast Cancer
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment
whole-genome expression after celecoxib treatment
Affymetrix arrays were performed on pre- and post treated (celecoxib and placebo) breast cancer tissues
No
Pierre SJ Hupperets, MD; PhD
Principal Investigator
Maastricht University Medical Centre
Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)
MUMC MEC 04-038
NCT01695226
February 2004
Name | Location |
---|